Tang Capital Management AUPH Position
ActiveTang Capital Management held their position in Aurinia Pharmaceuticals Inc. (AUPH) in Q4 2025, holding $180.7M worth of shares across 11,329,500 shares.
The position was first reported in Q2 2023 and has been tracked across 11 quarterly 13F filings.
1 other tracked fund also holds AUPH.
Tang Capital Management AUPH Position History
| Quarter | Action | Shares | Change | Value |
|---|---|---|---|---|
| Q4 2025 | Held | 11,329,500 | — | $180.7M |
| Q3 2025 | Increased | 11,329,500 | +1,300,000 | $125.2M |
| Q2 2025 | Held | 10,029,500 | — | $85.0M |
| Q1 2025 | Increased | 10,029,500 | +1,600,000 | $80.6M |
| Q4 2024 | Increased | 8,429,500 | +1,200,000 | $75.7M |
| Q3 2024 | Increased | 7,229,500 | +4,450,000 | $53.0M |
| Q2 2024 | Increased | 2,779,500 | +729,500 | $15.9M |
| Q1 2024 | Increased | 2,050,000 | +1,500,000 | $10.3M |
| Q4 2023 | Decreased | 550,000 | -200,000 | $4.9M |
| Q3 2023 | Increased | 750,000 | +600,000 | $5.8M |
| Q2 2023 | New | 150,000 | +150,000 | $1.5M |
Frequently Asked Questions
Does Tang Capital Management own AUPH?
Yes. As of Q4 2025, Tang Capital Management holds 11,329,500 shares of Aurinia Pharmaceuticals Inc. (AUPH) valued at $180.7M. This data comes from their SEC 13F filing.
How many hedge funds own AUPH?
2 specialist biotech hedge funds currently hold AUPH, including Rock Springs Capital. When 3 or more specialist funds hold the same stock, BiotechEdge flags it as a convergence signal.
When did Tang Capital Management first buy AUPH?
Tang Capital Management's position in AUPH was first reported in Q2 2023. 13F filings are reported with a 45-day delay, so the actual purchase may have occurred earlier in the quarter.
Is Tang Capital Management's AUPH position increasing or decreasing?
Tang Capital Management held their AUPH position unchanged in the most recent quarter.
Get the weekly biotech signal briefing
Fund moves, convergence shifts, insider buys, and catalyst alerts — delivered free every Monday.
AUPHCompany Page →
All fund holders, insider trades, catalysts, and cash runway
Tang Capital ManagementPortfolio →
Full 13F holdings, sector breakdown, and top movers
Drill into any signal
Fund Convergence
See which stocks multiple specialist funds are buying at once
Catalyst Calendar
Every PDUFA date, Phase 3 readout, and AdCom in one view
Insider Trading
When executives buy their own stock — the strongest bullish signal
Cash Runway
Which biotechs are running low on cash and face dilution risk
Short Squeeze
High short interest + fund buying + upcoming catalyst = squeeze setup
Signal Rankings
Every signal in one composite score — ranked by conviction
Biotech Movers
Stocks with the most signal activity right now across all signals
13F Changes
What top biotech funds bought and sold in the latest 13F filing
Want AI context on every signal? Start free trial →